L'intérêt à découvert pour Beyond donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Beyond. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Beyond (NYSE:BYON) Stock, Rapport sur les intérêts à découvert

BEYOND INC

Beyond

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Beyond Inc

On May 29, 2025, SOLOWIN HOLDINGS (the "Company") and certain individual investors (the "Purchasers") entered into that a securities purchase agreement (the "Purchase Agreement"), pursuant to which the Company agreed to sell to such Purchasers an aggregate of 20,000,000 Class A Ordinary Shares, par value $0.0001 per share (the "Class A Ordinary Shares") together with warrants to purchase up to 1,000,000 Class A Ordinary Shares, in a registered direct offering, pursuant to the Company's effective shelf registration statement on <a href="http://www.sec.gov/Archives/edgar/data/1959224/000121390024090558/ea0218561-f3a1_solowin.htm">Form F-3</a> (File No. 333-282552), for aggregate gross proceeds of $6,600,000, excluding the proceeds, if any, from the exercise of the warrants (the "Financing").
&nbsp;
The warrants have a term of 3 years and will be exercisable for cash immediately following the date of issuance and have an exercise price of $0.363. A holder of the warrants also will have the right to exercise its warrants on a cashless basis starting one month after the issuance. Each warrant is subject to standard anti-dilution provisions to reflect share dividends, splits or other similar transactions.
&nbsp;
The Company intends to use the net proceeds from the Financing for working capital and general corporate purposes. The Financing is expected to close on or about June 2, 2025, subject to the satisfaction of customary closing conditions.
&nbsp;

News

Offerings

SWIN

Solowin Holdings Announces $6.6M Registered Direct Offering Of 20M Class A Shares And 1M Warrants

In the current session, the stock is trading at $151.38, after a 0.21% spike. Over the past month, PJT Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) stock increased by 7.89%, and in the past year, by 41.45%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1748552417_0.png" alt="Past Year Chart" />

<h3>Comparing PJT Partners P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
PJT Partners has a better P/E ratio of 26.55 than the aggregate P/E ratio of 20.96 of the Capital Markets industry. Ideally, one might believe that PJT Partners Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748552417_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

A Look Into PJT Partners Inc's Price Over Earnings

Liberty Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) has outperformed the market over the past 10 years by 2.4% on an annualized basis producing an average annual return of 13.18%. Currently, Liberty Media has a market capitalization of $23.81 billion. 
Buying $100 In FWONK: If an investor had bought $100 of FWONK stock 10 years ago, it would be worth $350.98 today based on a price of $95.44 for FWONK at the time of writing.
<h3>Liberty Media's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748552413_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

FWONK

$100 Invested In Liberty Media 10 Years Ago Would Be Worth This Much Today

Fiscal 2025 Outlook
The below fiscal 2025 outlook does not reflect the potential effect of tariffs, which are currently 30% on most imports from China and 10% on most imports from other countries. If these tariff rates remain, they could result in a gross estimated incremental cost of approximately $250 million to $300 million. The company currently has strategies to mitigate more than half of that amount. After considering these mitigation strategies, the company estimates a remaining net impact of about $100 million to $150 million to fiscal 2025 operating income, primarily weighted to the back half of the year.

Guidance

Politics

General

Gap Projects $100M–$150M Net Impact To Fiscal 2025 Operating Income From Tariffs, Despite Mitigating Over Half Of Estimated $250M–$300M Gross Cost

NGL Energy Partners Is Guiding Fiscal 2026 Full-Year Consolidated Adjusted EBITDA To A Range Of $615M–$625M

WIIM

COST

COST stock has given up its prior gain. Costco shares were trading higher following better-than-expected Q3 financial results.

Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has outperformed the market over the past 5 years by 10.38% on an annualized basis producing an average annual return of 24.26%. Currently, Goldman Sachs Group has a market capitalization of $188.74 billion. 
Buying $100 In GS: If an investor had bought $100 of GS stock 5 years ago, it would be worth $302.54 today based on a price of $604.85 for GS at the time of writing.
<h3>Goldman Sachs Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748551512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Goldman Sachs Group 5 Years Ago Would Be Worth Today

Earnings

Earnings Misses

NGL Energy Partners Q4 EPS $(0.12) Misses $0.01 Estimate, Sales $971.07M Miss $1.35B Estimate

Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>), a company improving health through innovative tests that guide patient care, will present novel research aimed at enhancing the clinical management of patients with cutaneous melanoma (CM) and uveal melanoma (UM) at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, being held May 30-June 3, 2025, in Chicago. This includes the latest findings from Castle's ongoing collaboration with the National Cancer Institute's Surveillance, Epidemiology and End Results (NCI's SEER) Program Registries affirming the significant, independent risk stratification provided by DecisionDx-Melanoma in an expanded, real-world cohort of more than 13,500 patients who received the test as part of their melanoma care.
"Management decisions for melanoma patients, such as referrals for sentinel lymph node biopsy and surveillance intensity, are guided by a patient's risk of dying from their disease," said Merve Hasanov, M.D., oncologist and director of the division of medical oncology at The Ohio State University Comprehensive Cancer Center in Columbus, Ohio. "The findings being presented at ASCO demonstrate that the DecisionDx-Melanoma test can provide more precise mortality risk predictions based on a patient's unique tumor biology and can improve upon the population-based risk assessment provided by American Joint Committee on Cancer (AJCC) staging. This can, in turn, help clinicians tailor treatment approaches to individual patient needs."
Castle's presentations at ASCO will take place during the Melanoma/Skin Cancers poster session on Sunday, June 1, from 9 a.m. to 12 p.m. Central time in Hall A – Posters and Exhibits.

Biotech

CSTL

Castle Biosciences Announces It Will Present Research Aimed At Enhancing The Clinical Management Of Patients With Cutaneous Melanoma And Uveal Melanoma At The 2025 American Society Of Clinical Oncology Annual Meeting

Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) reported third-quarter financial results after the market close on Thursday. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/g45681310/costco-wholesale-corporation-reports-third-quarter-and-year-to-date-operating-results-for-fiscal-2">from the report</a>.
Q3 Earnings: Costco reported third-quarter revenue of $63.2 billion, beating&nbsp;analyst <a href="http://benzinga.com/quote/COST/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $63.19 billion. The membership-based retailer reported third-quarter adjusted earnings of $4.28 per share, beating analyst estimates of $4.13 per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Net sales for the third quarter were up 8% year-over-year.&nbsp;Total comparable sales were up 5.7% on a year-over-year basis. Here&#8217;s a breakdown of comparable sales growth by region:
<ul class="wp-block-list">
<li>U.S.: up 6.6%</li>
</ul>
<ul class="wp-block-list">
<li>Canada: up 2.9%</li>
</ul>
<ul class="wp-block-list">
<li>Other International: up 3.2%</li>
</ul>
Membership fees came in at $1.24 billion, up from $1.12 billion in the prior year's quarter. Costco raised the price of its annual store membership by five dollars in September 2024, marking the company's first membership price hike since 2017.
Costco said it operates 905 warehouses, including 624 in the U.S. The company ended the quarter with approximately $13.84 billion in cash and cash equivalents.
Costco executives will further discuss the quarter on a conference call with investors and analysts at 5 p.m. ET.
COST Price Action: <a href="http://benzinga.com/quote/cost" target="_blank" rel="noreferrer noopener">Costco shares</a> were up 0.32% in after-hours, trading at $1,008.74 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45678353/these-analysts-revise-their-forecasts-on-dicks-sporting-goods-after-q1-results">These Analysts Revise Their Forecasts On Dick&#8217;s Sporting Goods After Q1 Results</a></li>
<li><a href="https://www.benzinga.com/personal-finance/25/05/45673001/tariff-confusion-creates-the-perfect-storm-for-cybercriminals-consumer-scams-on-the-rise">Tariff Confusion Creates The &#8216;Perfect Storm&#8217; For Cybercriminals, Consumer Scams On The Rise</a></li>
</ul>
Photo: Steve Travelguide/Shutterstock.

After-Hours Center

Movers

Costco Q3 Earnings: Revenue Beat, EPS Beat, Comps Up 5.7%, Membership Fee Growth And More

Asset Sales

GATX

Wells Fargo To Sell Assets Of Rail Equipment Leasing Business To Joint Venture Between GATX And Brookfield Infrastructure Representing Book Value ~$4.4B As Well As Rail Finance Lease Portfolio

<ul>
<li>Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics</li>
<li>This partnership aims to create a framework for rapid diagnostics research, development and commercialization</li>
<li>Danaher, through its Centers for Enabling Precision Medicine, will provide support in all aspects of the development cycle across diagnostic modalities</li>
</ul>
WASHINGTON, May 29, 2025 /PRNewswire/ --&nbsp;Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) ("Danaher"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.
This partnership will utilize the newly opened Danaher Centers for Enabling Precision Medicine to support a more streamlined, end-to-end development process. The first product intended to be developed through this partnership will leverage technologies from Leica Biosystems, one of Danaher's subsidiaries. The initial focus will be on digital and computational pathology products and AI-assisted algorithms, to help clinicians better diagnose patients by identifying those who are most likely to benefit from targeted therapies.

Danaher Partners With AstraZeneca To Scale Precision Medicine, Including Developing Next Generation Of AI-Powered Diagnostics

Amyris takes full ownership of Brazilian precision fermentation plant and Ingredion obtains exclusive access to fermented Reb M technology
EMERYVILLE, Calif. and WESTCHESTER, Ill., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>), a leading global provider of ingredient solutions to the food manufacturing industry, today announced an agreement to wind down their RealSweet joint venture. As part of the agreement, Amyris will assume 100% ownership of the Precision Fermentation Plant in Barra Bonita, Brazil, and Ingredion will exclusively utilize Amyris' technology to manufacture and commercialize fermented Reb M, setting the foundation for commercial success and future collaboration between the companies.

INGR

Amyris And Ingredion Agree To Wind Down RealSweet JV; Amyris Assumes Full Ownership Of Precision Fermentation Plant In Barra Bonita, Ingredion Gains Exclusive Reb M Rights

American Eagle Outfitters Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) shares are trading lower on Thursday in after-hours following the retailer&#8217;s report of weaker-than-expected financial results for the first quarter of<a href="https://www.benzinga.com/pressreleases/25/05/b45680850/aeo-inc-reports-first-quarter-fiscal-2025-results"> fiscal 2025. </a>
What To Know: The company posted a net loss of $64.9 million or 36 cents per share, missing analyst expectations of a 23 cents profit. Revenue came in at $1.09 billion, falling short of the $1.24 billion estimate.
The results were potentially driven by a 5% year-over-year revenue decline and a sharp contraction in gross margins, which dropped from 40.6% last year to 29.6% this quarter. The company cited inventory writedowns, higher product costs and deeper markdowns as key factors. Comparable sales declined 3% overall, with Aerie down 4% and the American Eagle brand down 2%.
In response, American Eagle provided second-quarter guidance projecting $40 to $45 million in operating income, with comparable sales expected to decline 3%. However, the company withheld full-year guidance, citing macroeconomic uncertainty and the need to reassess plans after the weak first quarter.
Despite the weak performance, the company is continuing a $200 million accelerated share repurchase program and has slightly reduced its full-year capital expenditure forecast from $300 million to $275 million.
AEO Price Action: American Eagle shares were down 7.78% at $10.31 after-hours Thursday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45662671/tesla-targets-june-12-for-robotaxi-launch-in-austin-elon-musk-says-company-ramped-up-fsd-testing-a-month-ahead-of-schedule">Tesla Targets June 12 For Robotaxi Launch In Austin, Elon Musk Says Company Ramped Up FSD Testing &#8216;A Month Ahead Of Schedule&#8217; </a></li>
</ul>
Image Via Shutterstock.

American Eagle Outfitters Shares Drop After Posting Disappointing Q1 Results

Contracts

NMAX

Newsmax Announces It Has Entered Into A Multi-Year Renewal For Distribution With Verizon Fios For Its Cable Channel Newsmax.

Yatra Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTRA#NASDAQ">YTRA</a>) reported quarterly losses of $(0.01) per share. This is a 66.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported $25.66 million in sales this quarter. This is a 113.87 percent increase over sales of $12.00 million the same period last year.

YTRA

Yatra Online Q1 Adj. EPS $(0.01) Up From $(0.03) YoY, Sales $25.66M Up From $12.00M YoY

FEMY

Femasys shares are trading lower after the company announced a proposed public offering.

Cycurion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI,&nbsp;today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on May 22, 2025 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the "Form 10-Q"), as described more fully in the Company's Form NT 10-Q Notification of Late Filing (the "Form NT 10-Q") filed with the Securities and Exchange Commission (the "SEC") on May 15, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.

CYCU

Cycurion Receives Nasdaq Non-Compliance Notice Due To Delayed Quarterly Report

DUOT

Duos Technologies Group Files Supplement To Prospectus Relating To Offer And Sale Of Up To $10.50M Of Stock Through At-The-Market Offering

Zeo Energy shares are trading lower after the company announced it received a Nasdaq late filing notice.

Press Releases

Beyond, Inc. Provides Additional Details Regarding Overstock "O" Digital Asset Security

Beyond, Inc. Provides Additional Details Regarding buybuy BABY Digital Asset Security

Beyond, Inc. Scheduled to Release First Quarter 2025 Financial Results

Beyond, Inc. Announces the Launch of the Overstock 'O' Digital Asset Security Offering on the tZERO Platform

Beyond, Inc. Launches First-Ever 'O' Days Anniversary Event

Beyond, Inc. Delivers Significant Financial Improvement Across Key Operational Guideposts – Signals Imminent Shift to Revenue Growth Phase

Beyond, Inc. Announces the Early Closing Date of the Overstock "O" Digital Asset Security Offering on the tZERO Platform

Beyond, Inc. Announces the Launch of the 'BABY' Digital Asset Security Offering on the tZERO Platform

Beyond, Inc. Launches Iconic buybuy BABY Brand with Grand Online Re-Opening in Time for Mother's Day

Comments

Beyond

Intérêt court

Beyond (NYSE:BYON) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL